Artificial Intelligence driven Marketing Communications
According to a new market research report “Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%.
Factors driving the growth of Interventional Cardiology Devices Market include technological advancements in interventional cardiology devices, rising geriatric population, increasing incidence of cardiovascular diseases, and improving healthcare infrastructure in emerging markets.
The angioplasty stents market is further segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents. The drug-eluting stents segment is expected to account for the largest share of the global Interventional Cardiology Devices Market in 2017. Factors driving the growth of this segment include the wide range of benefits associated with the use of drug-eluting stents and the widespread availability of these devices across the globe.
The plaque modification devices market is further segmented into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is expected to account for the largest share of the global Interventional Cardiology Devices Market in 2017.
North America is estimated to dominate the Interventional Cardiology Devices Market in 2017. This is mainly due to factors such as the increasing patient base of cardiovascular diseases, technological advancements in interventional cardiology devices, and growing healthcare expenditures.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=548
Key Players In Interventional Cardiology Devices Market:
Major industry players launched innovative products to maintain and improve their position in the interventional cardiology devices market. Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany) have been identified as key players in this market. These companies have broad product portfolios with comprehensive features and have also launched innovative products. These leaders also have products for all end users in this market, strong geographical presence, and a focus on continuous product innovation.